Expression and purification of recombinant full-length NS3 protease–helicase from a new variant of Hepatitis C virus

By Poliakov A.   Hubatsch I.   Shuman C.F.   Stenberg G.   Danielson U.H.  

Protein Expression and Purification, Vol. 25, Iss. 3, 2002-08 ,pp. : 363-371

Academic Press

Access to resources Recommend Favorite

Structural Characterization of the Interactions of Optimized Product Inhibitors with the N-terminal Proteinase Domain of the Hepatitis C Virus (HCV) NS3 Protein by NMR and Modelling Studies

By Cicero D.O.   Barbato G.   Koch U.   Ingallinella P.   Bianchi E.   Nardi M.C.   Steinkühler C.   Cortese R.   Matassa V.   de Francesco R.   Pessi A.   Bazzo R.  

Journal of Molecular Biology, Vol. 289, Iss. 2, 1999-06 ,pp. : 385-396

Academic Press

Access to resources Recommend Favorite

Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease

By  

Protein and Peptide Letters, Vol. 21, Iss. 8, 2014-06 ,pp. : 815-827

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus

By Frecer V.   Kabelac M.   De Nardi P.   Pricl S.   Miertus S.  

Journal of Molecular Graphics and Modelling, Vol. 22, Iss. 3, 2004-01 ,pp. : 209-220

Elsevier

Access to resources Recommend Favorite

The RNA Aptamer-Binding Site of Hepatitis C Virus NS3 Protease

By Hwang J.   Fauzi H.   Fukuda K.   Sekiya S.   Kakiuchi N.   Shimotohno K.   Taira K.   Kusakabe I.   Nishikawa S.  

Biochemical and Biophysical Research Communications, Vol. 279, Iss. 2, 2000-12 ,pp. : 557-562

Elsevier

Access to resources Recommend Favorite